Key result
Nitric oxide serves as a key endothelium-derived relaxing factor regulating vascular tone, and its impaired bioavailability is a major cardiovascular risk factor contributing to endotheliopathies.
This review highlights the critical role of endothelium-derived nitric oxide in regulating vascular tone and the detrimental cardiovascular consequences of endothelial dysfunction.
Endothelial NO assessment may refine vascular risk stratification; confirms regulatory role yet leaves therapeutic targeting open for trials.
Vascular endothelium plays a key role in the local regulation of vascular tone and vascular architecture by release of vasodilator and vasoconstrictor substances, as well as factors with pro-coagulant, anticoagulant, fibrinolytic, antibacterial properties, growth factors, chemokines, free radicals, etc. Release of endothelium-derived relaxing factors such as nitric oxide (NO), prostaglandins and endothelium-derived hyperpolarizing factor, as well as vasoconstricting factors such as endothelin, superoxide and thromboxanes play an influential role in the maintenance and regulation of vascular tone and the corresponding peripheral vascular resistance. Under physiological conditions, the release of anticoagulant and smooth muscle relaxing factors exceeds the release of other substances. The first part of this review presents the functions of the endothelium itself, the nature of the endothelium-derived relaxing factor, its production by NO synthases, mechanisms of its action via activation of soluble guanylyl cyclase and production of cyclic 3'-5'-guanosine monophosphate. The resulting biological effects include vasodilatation, regulation of vessel wall structure, increased regional blood perfusion, lowering of systemic blood pressure, antithrombosis and antiatherosclerosis effects, which counteract the vascular actions of endogenous vasoconstrictor substances. Impaired endothelial function, either as a consequence of reduced production/release or increased inactivation of endothelium-derived vasodilators, as well as interactions of NO with angiotensin, reactive oxygen species and oxidized lipoproteins, has detrimental functional consequences and is one of the most important cardiovascular risk factors. Therefore the second part of this review assesses the pathophysiologic impact of the endothelium in examples of cardiovascular pathologies, e.g. endotheliopathies caused by increased angiotensin production, lipid peroxidation, ischemia/reperfusion or diabetes.
No takes yet. Share an insight, caveat, or question.
Bauer et al. (2010) conducted a review in Cardiovascular diseases. Nitric oxide was evaluated. Nitric oxide serves as a key endothelium-derived relaxing factor regulating vascular tone, and its impaired bioavailability is a major cardiovascular risk factor contributing to endotheliopathies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: